Eric Drape - 04 Mar 2022 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
Executive VP Global Operations
Signature
/s/ Dov Bergwerk as attorney-in-fact for Eric Drape
Issuer symbol
TEVA
Transactions as of
04 Mar 2022
Net transactions value
-$259,019
Form type
4
Filing time
08 Mar 2022, 15:05:35 UTC
Previous filing
02 Mar 2022
Next filing
09 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TEVA Ordinary Shares Options Exercise +32,518 +71% 78,348 04 Mar 2022 Direct F1, F2
transaction TEVA Ordinary Shares Sale $128,377 -17,157 -22% $7.48 61,191 04 Mar 2022 Direct F1, F3, F4, F5
transaction TEVA Ordinary Shares Options Exercise +11,940 +20% 73,131 04 Mar 2022 Direct F1, F2
transaction TEVA Ordinary Shares Sale $47,147 -6,301 -8.6% $7.48 66,830 04 Mar 2022 Direct F1, F3, F4, F5
transaction TEVA Ordinary Shares Options Exercise +22,576 +34% 89,406 05 Mar 2022 Direct F1, F2
transaction TEVA Ordinary Shares Sale $83,494 -11,334 -13% $7.37 78,072 07 Mar 2022 Direct F1, F3, F4, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Options Exercise $0 -32,518 -100% $0.000000* 0 04 Mar 2022 Ordinary Shares 32,518 Direct F1, F2, F7
transaction TEVA Restricted Share Units Options Exercise $0 -11,940 -50% $0.000000 11,940 04 Mar 2022 Ordinary Shares 11,940 Direct F1, F2, F8
transaction TEVA Restricted Share Units Award $0 +134,048 $0.000000 134,048 04 Mar 2022 Ordinary Shares 134,048 Direct F1, F2, F9
transaction TEVA Restricted Share Units Options Exercise $0 -22,576 -25% $0.000000 67,728 05 Mar 2022 Ordinary Shares 22,576 Direct F1, F2, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F3 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F4 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.40 to $7.60, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.30 to $7.49, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
F7 Restricted share units were received on February 8, 2022 upon satisfaction of performance criteria and vested on March 4, 2022.
F8 Restricted share units were granted on March 4, 2019, with 11,940 having vested on each of March 4, 2021 and March 4, 2022, and 11,940 vesting on March 4, 2023.
F9 Restricted share units were granted on March 4, 2022, with 33,512 vesting on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026.
F10 Restricted share units were granted on March 5, 2021, with 22,576 having vested on March 5, 2022 and 22,576 vesting on each of March 5, 2023, March 5, 2024 and March 5, 2025.